Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
50 participants
OBSERVATIONAL
2011-05-31
2014-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Telemedicine for Reach, Education, Access, and Treatment for Diabetes Self-Management Education and Support
NCT06626347
Teleconsultation in Type 1 Diabetes Mellitus
NCT02812498
Effectiveness and Cost-effectiveness of a Telemonitoring Program for Diabetic People at Home
NCT01955031
Therapeutic Education Consultations With Diabetic Patients Treated With Intensified Insulin Therapy
NCT06167499
Impact of Telehealth Education in Diabetes Patients
NCT05696015
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient with the electronic pad in a smartphone
* adults
* children between 12 and 17 years 11 months
* patient having signed the consent
Exclusion Criteria
* patient without the electronic pad in a smartphone
* children below 12 years old
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-A00311-40
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.